BACKGROUND: Spontaneous and iatrogenic secondary peritonitis remain to have a mortality of 10-30% and significant socioeconomic impact in survivors and especially non-survivors. Data on the most cost-effective treatment are lacking. We therefore studied outcome and resource utilization in a homogeneous cohort of patients with secondary fecal or purulent peritonitis undergoing surgery with source control and two different types of abdominal lavage. METHODS: Thirty-one consecutive patients with secondary feculent or purulent peritonitis of the lower gastrointestinal tract underwent a single high-volume lavage. That cohort was matched with 31 patients with the same source, extent, and quality of peritonitis treated by source control and staged lavage (intermittent lavage). RESULTS: Patients in both groups were comparable in gender distribution, age, comorbidity, source, extent, and severity of peritonitis with the history of intestinal perforation in the single high-volume lavage group being significantly higher than in the intermittent lavage group (2.0 +/- 1.7 vs. 1.1 +/- 0.8d; p = 0.008). Patients in the single high-volume lavage group had significantly less operations, thus requiring significantly less operation time (OR-time), intensive care unit (ICU)-requirement, ventilatory support, and inotropic support. CONCLUSION: Patients with secondary fecal or purulent peritonitis in at least two quadrants, undergoing a one step surgical repair including source control, primary anastomosis, and single high-volume lavage with more than 25 l have a comparable outcome to patients treated by staged lavage at significantly lower OR and ICU-utilization.
BACKGROUND: Spontaneous and iatrogenic secondary peritonitis remain to have a mortality of 10-30% and significant socioeconomic impact in survivors and especially non-survivors. Data on the most cost-effective treatment are lacking. We therefore studied outcome and resource utilization in a homogeneous cohort of patients with secondary fecal or purulent peritonitis undergoing surgery with source control and two different types of abdominal lavage. METHODS: Thirty-one consecutive patients with secondary feculent or purulent peritonitis of the lower gastrointestinal tract underwent a single high-volume lavage. That cohort was matched with 31 patients with the same source, extent, and quality of peritonitis treated by source control and staged lavage (intermittent lavage). RESULTS:Patients in both groups were comparable in gender distribution, age, comorbidity, source, extent, and severity of peritonitis with the history of intestinal perforation in the single high-volume lavage group being significantly higher than in the intermittent lavage group (2.0 +/- 1.7 vs. 1.1 +/- 0.8d; p = 0.008). Patients in the single high-volume lavage group had significantly less operations, thus requiring significantly less operation time (OR-time), intensive care unit (ICU)-requirement, ventilatory support, and inotropic support. CONCLUSION:Patients with secondary fecal or purulent peritonitis in at least two quadrants, undergoing a one step surgical repair including source control, primary anastomosis, and single high-volume lavage with more than 25 l have a comparable outcome to patients treated by staged lavage at significantly lower OR and ICU-utilization.
Authors: Sven Richter; Werner Lindemann; Otto Kollmar; Georg A Pistorius; Christoph A Maurer; Martin K Schilling Journal: World J Surg Date: 2006-06 Impact factor: 3.352
Authors: Philippe Montravers; Hervé Dupont; Remy Gauzit; Benoit Veber; Christian Auboyer; Patrick Blin; Christophe Hennequin; Claude Martin Journal: Crit Care Med Date: 2006-03 Impact factor: 7.598
Authors: Bettina M Rau; Isabella Frigerio; Markus W Büchler; Karl Wegscheider; Claudio Bassi; Pauli A Puolakkainen; Hans G Beger; Martin K Schilling Journal: Arch Surg Date: 2007-02
Authors: Oddeke van Ruler; Cecilia W Mahler; Kimberly R Boer; E Ascelijn Reuland; Hein G Gooszen; Brent C Opmeer; Peter W de Graaf; Bas Lamme; Michael F Gerhards; E Philip Steller; J W Olivier van Till; Corianne J A M de Borgie; Dirk J Gouma; Johannes B Reitsma; Marja A Boermeester Journal: JAMA Date: 2007-08-22 Impact factor: 56.272
Authors: Hassan Mashbari; Mohannad Hemdi; Kevin L Chow; James C Doherty; Gary J Merlotti; Steven L Salzman; Eduardo Smith Singares Journal: Bull Emerg Trauma Date: 2018-04
Authors: Sven Richter; Stefan Dold; Johannes P Doberauer; Peter Mai; Jochen Schuld Journal: Gastroenterol Res Pract Date: 2013-10-28 Impact factor: 2.260